Ovarian Cancer Australia announces leadership change with appointment of new CEO

Latest News

Ovarian Cancer Australia has announced that its leader of eight years, Jane Hill, will be succeeded by Associate Professor Anna Boltong.

The organisation paid tribute to Ms Hill for building the organisation in terms of people and its financial position.

Chair Meghan Speers said, "Our people, Board and Community are so very grateful for Jane’s leadership and her genuine passion for our mission.

"Jane’s steadfast leadership and dedication to governance and advocacy has transformed the organisation and its service offering over her time leading the organisation. Anna has a deep passion for improving outcomes for women impacted by Ovarian Cancer. Anna brings a wealth of knowledge driving system change within the cancer space and we were impressed at her approach to collaboration both internally within organisations, but also across the sector.”

Associate Professor Boltong was most recently the head of cancer control strategy at Cancer Australia.

“I am thrilled to carry on Jane’s work. Under her leadership, OCA has inspired us with their tireless advocacy on behalf of women in Australia, and I look forward to continuing this important work,” she said.